Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SCH 48461

Known as: SCH-48461 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2002
Highly Cited
2002
Intestinal cholesterol absorption is a major determinant of plasma low density lipoprotein-cholesterol (LDL-C) concentrations… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Highly Cited
2001
Highly Cited
2001
Ezetimibe (SCH 58235) and SCH 48461 are potent cholesterol absorption inhibitors, which cause significant decreases in plasma… Expand
2001
2001
SCH 48461, an inhibitor of gastrointestinal absorption of cholesterol, was evaluated for its effects on lipid parameters in… Expand
Highly Cited
1998
Highly Cited
1998
(3R)-(3-Phenylpropyl)-1,(4S)-bis(4-methoxyphenyl)-2-azetidinone (2, SCH 48461), a novel inhibitor of intestinal cholesterol… Expand
1997
1997
Changes in the dissolution of a solid dispersion capsule formulation composed of amorphous SCH 48461 in a polyethylene glycol… Expand
Highly Cited
1996
Highly Cited
1996
A series of azetidinone cholesterol absorption inhibitors related to SCH 48461 ((-)-6) has been prepared, and compounds were… Expand
1996
1996
Clinical Pharmacology & Therapeutics (1996) 59, 194–194; doi: 10.1038/sj.clpt.1996.274 
Highly Cited
1995
Highly Cited
1995
The amount of cholesterol that circulates in the plasma as lipoproteins can be affected by the balance of cholesterol metabolism… Expand